Drug profile · INN
adefovir dipivoxil
HEPSERA
adefovir dipivoxil (HEPSERA) is a dna polymerase/reverse transcriptase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — adefovir dipivoxil
- US status
- approved
- Class
- Antiinfectives for systemic use (J05)
- Route
- ORAL
- Patents
- 10
- Programs
- 6
- Data quality
- 0.84
Quick answer
adefovir dipivoxil (HEPSERA) is a dna polymerase/reverse transcriptase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA polymerase/reverse transcriptase inhibitor
Primary target: DNA polymerase/reverse transcriptase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12377106
Piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and for degrading BTK
granted -
US 12234230
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
granted -
US 12049471
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
granted -
US 11951133
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
granted -
US 11866442
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted -
US 11820781
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted -
US 11530229
Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
granted -
US 11479556
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted -
US 11464802
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
granted -
US 11401267
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
granted
Frequently asked questions
What is adefovir dipivoxil?
adefovir dipivoxil (HEPSERA) is a dna polymerase/reverse transcriptase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for adefovir dipivoxil?
HEPSERA is a marketed brand name for adefovir dipivoxil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of adefovir dipivoxil?
adefovir dipivoxil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.